My impression is they are having a go at filling the gap until the P&G product comes out.I think P&G will be using 'stronger' ant-TMa compounds than DMB, and DMB just proved the principle.I have low expectations of DMB effect etc but support what Dermetel are doing.

As far as I know no-one received their shipment.They have also upped the price to £300.I know DMB is expensive but ...

I hope everyone who asked for a refund got it.So I couldn't suggest buying this experimental product for now.

The company fall into the category : grassroots start-up.We have had a few have a go in this category and we need to take it as a big risk I guess. Really we need more, but they keep hitting obstacles etc.

It seems in this case getting a shipping via air licence for a volatile liquid was a major hurdle, maybe unsolveable.

I guess we have on the horizon the P&G tma-inhibitor product which might be 3-5 years away.